These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8219421)

  • 1. Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany.
    Schallreuter KU; Levenig C; Kühnl P; Löliger C; Hohl-Tehari M; Berger J
    Dermatology; 1993; 187(3):186-92. PubMed ID: 8219421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population.
    Taştan HB; Akar A; Orkunoğlu FE; Arca E; Inal A
    Pigment Cell Res; 2004 Apr; 17(2):181-4. PubMed ID: 15016308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients.
    Orecchia G; Perfetti L; Malagoli P; Borghini F; Kipervarg Y
    Dermatology; 1992; 185(2):123-7. PubMed ID: 1421624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo.
    Singh A; Sharma P; Kar HK; Sharma VK; Tembhre MK; Gupta S; Laddha NC; Dwivedi M; Begum R; ; Gokhale RS; Rani R
    J Invest Dermatol; 2012 Jan; 132(1):124-34. PubMed ID: 21833019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA loci alleles and antigens in Saudi patients with vitiligo.
    Abanmi A; Al Harthi F; Al Baqami R; Al Assaf S; Zouman A; Arfin M; Tariq M
    Arch Dermatol Res; 2006 Dec; 298(7):347-52. PubMed ID: 17021767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations.
    Buc M; Busová B; Hegyi E; Kolibásová K
    Folia Biol (Praha); 1996; 42(1-2):23-5. PubMed ID: 8831023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of human leukocyte antigen-cw in Egyptian patients with vitiligo.
    Hassab El Naby HM; Alnaggar MR; Abdelhamid MF; Alsaid K; Al Shawadfy EM; Elsaie ML
    J Drugs Dermatol; 2015 Apr; 14(4):359-64. PubMed ID: 25844609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in Omani patients with vitiligo.
    Venkataram MN; White AG; Leeny WA; al Suwaid AR; Daar AS
    Clin Exp Dermatol; 1995 Jan; 20(1):35-7. PubMed ID: 7671393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC haplotypic association in Chinese Han patients with vitiligo.
    Xia Q; Zhou WM; Liang YH; Ge HS; Liu HS; Wang JY; Gao M; Yang S; Zhang XJ
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):941-6. PubMed ID: 16922942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type.
    Ando I; Chi HI; Nakagawa H; Otsuka F
    Br J Dermatol; 1993 Oct; 129(4):408-10. PubMed ID: 8217754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HL-A antigens and vitiligo.
    Retornaz G; Betuel H; Ortonne JP; Thivolet J
    Br J Dermatol; 1976 Aug; 95(2):173-5. PubMed ID: 952754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients.
    al-Fouzan A; al-Arbash M; Fouad F; Kaaba SA; Mousa MA; al-Harbi SA
    Eur J Immunogenet; 1995 Apr; 22(2):209-13. PubMed ID: 7605779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo: a study of patients with vitiligo from southeast Brazil.
    Ramire LD; Marcos EV; Godoy DA; de Souza-Santana FC
    Int J Dermatol; 2016 Jun; 55(6):e347-55. PubMed ID: 26769539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients.
    Schallreuter KU; Lemke R; Brandt O; Schwartz R; Westhofen M; Montz R; Berger J
    Dermatology; 1994; 188(4):269-75. PubMed ID: 8193398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
    Fain PR; Babu SR; Bennett DC; Spritz RA
    Pigment Cell Res; 2006 Feb; 19(1):51-7. PubMed ID: 16420246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans.
    Yang S; Wang JY; Gao M; Liu HS; Sun LD; He PP; Liu JB; Zhang AP; Cui Y; Liang YH; Wang ZX; Zhang XJ
    Int J Dermatol; 2005 Dec; 44(12):1022-7. PubMed ID: 16409268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.
    Cavalli G; Hayashi M; Jin Y; Yorgov D; Santorico SA; Holcomb C; Rastrou M; Erlich H; Tengesdal IW; Dagna L; Neff CP; Palmer BE; Spritz RA; Dinarello CA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1363-8. PubMed ID: 26787888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA associations in vitiligo patients in the Dutch population.
    Venneker GT; de Waal LP; Westerhof W; D'Amaro J; Schreuder GM; Asghar SS
    Dis Markers; 1993 Nov; 11(4):187-90. PubMed ID: 8112023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
    Li YL; Yu CL; Yu HS
    J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.